A detailed history of Deutsche Bank Ag\ transactions in Abb Vie Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 7,666,829 shares of ABBV stock, worth $1.37 Billion. This represents 0.63% of its overall portfolio holdings.

Number of Shares
7,666,829
Previous 7,905,780 3.02%
Holding current value
$1.37 Billion
Previous $1.36 Billion 11.66%
% of portfolio
0.63%
Previous 0.62%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $39.1 Million - $47.6 Million
-238,951 Reduced 3.02%
7,666,829 $1.51 Billion
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $74.5 Million - $87 Million
-481,517 Reduced 5.74%
7,905,780 $1.36 Billion
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $182 Million - $208 Million
1,141,793 Added 15.76%
8,387,297 $1.53 Billion
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $326 Million - $367 Million
2,370,693 Added 48.63%
7,245,504 $1.12 Billion
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $163 Million - $189 Million
-1,219,010 Reduced 20.0%
4,874,811 $727 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $69.6 Million - $86.7 Million
525,570 Added 9.44%
6,093,821 $821 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $37.7 Million - $43.4 Million
-260,656 Reduced 4.47%
5,568,251 $887 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $5.59 Million - $6.7 Million
40,387 Added 0.7%
5,828,907 $943 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $111 Million - $127 Million
-827,922 Reduced 12.51%
5,788,520 $777 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $165 Million - $210 Million
1,198,823 Added 22.13%
6,616,442 $1.01 Billion
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $97.2 Million - $121 Million
-736,561 Reduced 11.97%
5,417,619 $878 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $4.91 Million - $6.21 Million
45,691 Added 0.75%
6,154,180 $833 Million
Q3 2021

Nov 04, 2021

SELL
$106.4 - $120.78 $74.6 Million - $84.7 Million
-700,907 Reduced 10.29%
6,108,489 $659 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $43 Million - $47.9 Million
408,252 Added 6.38%
6,809,396 $767 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $212 Million - $234 Million
-2,075,861 Reduced 24.49%
6,401,144 $693 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $282 Million - $381 Million
-3,507,205 Reduced 29.27%
8,477,005 $908 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $295 Million - $346 Million
3,429,344 Added 40.09%
11,984,210 $1.05 Billion
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $28.1 Million - $37.6 Million
383,081 Added 4.69%
8,554,866 $840 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $57.8 Million - $87.6 Million
895,838 Added 12.31%
8,171,785 $623 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $61.7 Million - $77.2 Million
-855,113 Reduced 10.52%
7,275,947 $644 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $2.89 Million - $3.48 Million
45,949 Added 0.57%
8,131,060 $616 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $41.6 Million - $53.2 Million
633,773 Added 8.51%
8,085,111 $588 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $174 Million - $205 Million
2,253,595 Added 43.36%
7,451,338 $600 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $114 Million - $141 Million
-1,469,781 Reduced 22.04%
5,197,743 $479 Million
Q3 2018

Dec 21, 2021

BUY
$88.91 - $98.84 $171 Million - $190 Million
1,925,443 Added 40.6%
6,667,524 $631 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $288 Million - $321 Million
-3,244,267 Reduced 40.62%
4,742,081 $448 Million
Q2 2018

Apr 21, 2020

BUY
$89.78 - $106.23 $171 Million - $202 Million
1,903,369 Added 31.29%
7,986,348 $740 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $367 Million - $434 Million
-4,089,012 Reduced 40.2%
6,082,979 $564 Million
Q1 2018

Oct 18, 2019

BUY
$92.01 - $123.21 $283 Million - $379 Million
3,076,703 Added 43.36%
10,171,991 $963 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $270 Million - $361 Million
2,930,952 Added 70.38%
7,095,288 $672 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $38.3 Million - $42 Million
-427,537 Reduced 9.31%
4,164,336 $403 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $321 Million - $410 Million
4,591,873
4,591,873 $408 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.